CENTRAL GARDEN & PET CO
For the period ended Dec 28, 2024. Filed Feb 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 28, 2024 · Filed Feb 6, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-06-29; filed 2024-08-08.
0000887733-24-000023
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2024-12-28; filed 2025-02-06.
0000887733-25-000006
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 12 previous paragraphs and 28 current paragraphs.
6 unchanged; 5 reworded; 6 added; 1 removed; 0 previous and 11 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (6)
Current report
(1)In August 2019, our Board of Directors authorized a share repurchase program to purchase up to $100 million of our common stock
Current report
Authorization and 2019 Repurchase Authorization, collectively.
Current report
(4)During the period, we repurchased 1,677,632 shares under the two programs, 1,321,243 CENTA shares and 356,389 CENT
Current report
shares, including 37,563 shares repurchased under the Equity Dilution Authorization and 1,640,069 shares repurchased under the
Current report
2019 Repurchase Authorization.
Removed paragraphs (1)
Previous report
(4)Excludes 0.3 million shares remaining under our Equity Dilution Authorization as of June 29, 2024.
Reworded paragraphs (5)
Previous wording
There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 30, 2023.
Current wording
There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year
Previous wording
The following table sets forth the repurchases of any equity securities during the fiscal quarter ended June 29, 2024 and the dollar amount of authorized share repurchases remaining under our stock repurchase program.
Current wording
The following table sets forth the repurchases of any equity securities during the fiscal quarter ended December 28, 2024 and the dollar
Previous wording
(1)During the fourth quarter of fiscal 2019, our Board of Directors authorized a $100 million share repurchase program, (the "2019 Repurchase Authorization"). The 2019 Repurchase Authorization has no fixed expiration date and expires when the amount authorized has been used or the Board withdraws its authorization. The repurchase of shares may be limited by certain financial covenants in our credit facility that restrict our ability to repurchase our stock. As of June 29, 2024, we had $82.0 million of authorization remaining under our 2019 Repurchase Authorization.
Current wording
(the "2019 Repurchase Authorization”). The 2019 Repurchase Authorization has no fixed expiration date and expires when the
Previous wording
(2)In February 2019, our Board of Directors authorized us to make supplemental stock purchases to minimize dilution resulting from issuances under our equity compensation plans (the "Equity Dilution Authorization"). In addition to our regular share repurchase program, we are permitted to purchase annually a number of shares equal to the number of shares of restricted stock and stock options granted in the prior fiscal year, to the extent not already repurchased, and the current fiscal year. The Equity Dilution Authorization has no fixed expiration date and expires when the Board withdraws its authorization.
Current wording
(2)In February 2019, our Board of Directors authorized us to make supplemental stock purchases to minimize dilution resulting from
Previous wording
(3)Shares purchased during the period indicated represent withholding of a portion of shares to cover taxes in connection with the vesting of restricted stock and do not reduce the dollar value of shares that may be purchased under our stock repurchase plan.
Current wording
vesting of restricted stock and do not reduce the dollar value of shares that may be purchased under our stock repurchase plan.
Rearranged current paragraphs (11)
Current report — wording carried from elsewhere
amount of authorized share repurchases remaining under our stock repurchase programs.
Current report — wording carried from elsewhere
amount authorized has been used or the Board withdraws its authorization. In December 2024, our Board of Directors authorized a
Current report — wording carried from elsewhere
$100 million increase in the share repurchase program, (the "2024 Repurchase Authorization"). The 2024 Repurchase
Current report — wording carried from elsewhere
Authorization has no fixed expiration date and expires when the amount authorized has been used or the Board withdraws its
Current report — wording carried from elsewhere
authorization. The repurchase of shares may be limited by certain financial covenants in our credit facility that restrict our ability to
Current report — wording carried from elsewhere
repurchase our stock. As of December 28, 2024, we had $131 million of authorization remaining under our 2024 Repurchase
Current report — wording carried from elsewhere
issuances under our equity compensation plans (the “Equity Dilution Authorization”). In addition to our 2019 and 2024 Repurchase
Current report — wording carried from elsewhere
Authorizations, we are permitted to purchase annually a number of shares equal to the number of shares of restricted stock and
Current report — wording carried from elsewhere
stock options granted in the prior fiscal year, to the extent not already repurchased, and the current fiscal year. The Equity Dilution
Current report — wording carried from elsewhere
Authorization has no fixed expiration date and expires when the Board withdraws its authorization.
Current report — wording carried from elsewhere
(3)Shares purchased during the period indicated include withholding of a portion of shares to cover taxes in connection with the